Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-01-03 @ 6:56 AM
Study NCT ID:
NCT02350569
Status:
COMPLETED
Last Update Posted:
2018-11-19
First Post:
2015-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-26
First Submit QC Date:
None
Study First Post Date:
2015-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-27
Results First Submit QC Date:
None
Results First Post Date:
2017-05-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-19
Last Update Post Date Type:
ACTUAL